Cynergistek, Inc CTEK
We take great care to ensure that the data presented and summarized in this overview for CYNERGISTEK, INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in CTEK
Top Purchases
Top Sells
About CTEK
CynergisTek, Inc. provides cyber security, privacy, and compliance services in the United States. The company identifies, measures, and tests security and privacy risk of organization, as well as verifies and validates their programs to meet compliance and business objectives through IT audits, technical testing, and risk and program assessments; develops policies, procedures, and playbooks to help build out a risk management program; and verifies the processes, people, and technology are working effectively. It also provides insights to the ROI of an organization's security investment; resources to help organizations prioritize, implement, and execute initiatives to strengthen their security and privacy programs; and on-going management and oversight organization's security and privacy programs to address or give alerts when an issue arises. It serves primarily in the healthcare industry, as well as education, financial services, government, internet and media, and manufacturing industries under the CynergisTek, Redspin, and Backbone Consulting brands. The company was formerly known as Auxilio, Inc. and changed its name to CynergisTek, Inc. in September 2017. CynergisTek, Inc. was incorporated in 1995 and is based in Austin, Texas.
Insider Transactions at CTEK
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 01
2022
|
Michael Henry Mcmillan President & CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
663,333
-100.0%
|
-
|
Sep 01
2022
|
Robert Mccashin Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
99,500
-100.0%
|
-
|
Sep 01
2022
|
Robert Mccashin Director |
SELL
Grant, award, or other acquisition
|
Direct |
35,000
-26.02%
|
-
|
Sep 01
2022
|
Theresa Zak Meadows Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
89,500
-100.0%
|
-
|
Sep 01
2022
|
Theresa Zak Meadows Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+21.83%
|
-
|
Sep 01
2022
|
Michael Ross Loria Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
50,000
-100.0%
|
-
|
Sep 01
2022
|
Michael Ross Loria Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+33.33%
|
-
|
Sep 01
2022
|
Mark D. Roberson Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
96,000
-100.0%
|
-
|
Sep 01
2022
|
Mark D. Roberson Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+20.66%
|
-
|
Sep 01
2022
|
Dana Davis Sellers Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
70,000
-100.0%
|
-
|
Sep 01
2022
|
Dana Davis Sellers Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+26.32%
|
-
|
Sep 01
2022
|
John Lawrence Sr Flood Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
100,000
-100.0%
|
-
|
Sep 01
2022
|
John Lawrence Sr Flood Director |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+28.57%
|
-
|
Sep 01
2022
|
Paul Thomas Anthony CFO, Secretary |
SELL
Sale (or disposition) back to the issuer
|
Direct |
327,277
-100.0%
|
-
|
Sep 01
2022
|
Paul Thomas Anthony CFO, Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
70,000
+17.62%
|
-
|
Dec 01
2021
|
Michael Henry Mcmillan President & CEO |
BUY
Open market or private purchase
|
Direct |
10,000
+1.63%
|
$10,000
$1.44 P/Share
|
Dec 01
2021
|
Robert Mccashin Director |
BUY
Open market or private purchase
|
Direct |
8,000
+7.44%
|
$8,000
$1.51 P/Share
|
Nov 16
2021
|
John Lawrence Sr Flood Director |
BUY
Open market or private purchase
|
Direct |
35,000
+25.93%
|
$35,000
$1.75 P/Share
|
Nov 15
2021
|
Michael Ross Loria Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+33.33%
|
-
|
Nov 15
2021
|
Theresa Zak Meadows Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+29.59%
|
-
|